Table 6.

bivariate and multivariate analysis of triglyceride-glucose index against cardiovascular risk factors and clinical outcomes among the COVID-19 patients admitted to Mengo Hospital Treatment Unit from December 2020 to August 2021 (N=314)

Variable	Unadjusted odds ratio (95% CI)	P-value	Adjusted odds ratio (95% CI)	P-value
Systolic blood pressure
<140mmHg	1		1
≥140mmHg	0.158(-0.315-0.622)	0.521	0.179(-0.412-0.0.712)	0.496
Diastolic blood pressure
<90mmHg	1		1
≥90mmHg	0.145(-0.263-0.553	0.485	0.168(-0.332-0.657	0.514
Glycated hemoglobin
<6.5%	1		1
≥6.5%	1.039(0.537-1.54)	<0.001	1.029(0.561-1.496)	<0.001
Low-density cholesterol
<2.82mmol/l	1		1
≥2.82mmol/l	0.129(0.023-0.235)	0.017	0.121(0.023-0.219)	0.016
Non-high-density cholesterol
<3.33mmol/l	1		1
≥3.33mmol/l	2.438(-0.381-5.260)	0.09	2.066(0.709-5.948)	0.185
High-density cholesterol
≥1.3mmol/l	1		1
<1.3mmol/l	1.587(1.056-2.85)	0.026	1.956(1.299-2.945)	0.001
Total cholesterol
<5.13 mmol/l	1		1
≥5.13mmol/l	1.599(1.411-1.811)	<0.001	2.177(1.522-3.144)	<0.001
Hospital death
No	1		1
Yes	1.141(0.921-1.415)	0.025	0.778(0.623-0.972)	0.029
Composite outcome
No	1		1
Yes	1.136(0.452-2-888)	0.034	1.823(1.22-2.559)	0.021
CT scan findings
Normal	1		1
≥CORADS 1	2.82(1.71-4.666)	<0.001	1.160(0.710-1.897)	0.553

CO-RADS: COVID-19 reporting and data system; CT: computerized tomography; CI: confidence interval